Wikipedia -WSS

Wikipedia

author：comprehensive 2025-10-01 13:58:29 - browse：2231

What happens when an approved drug doesn’t work? Why don’t patients want gene therapy? And is MASH still a big deal?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Bioethicist Holly Fernandez Lynch joins us to discuss the case of Amylyx Pharmaceuticals’ treatment for ALS and what its failure means for drug development. We also discuss the latest news in the life sciences, including a tepid reception for gene therapies, the future of CAR-T cancer treatment, and the first approved medicine for a prevalent liver disease.

For more on what we cover, here’s more on Amylyx; here’s the story on hemophilia gene therapy; here’s the news on Madrigal Pharmaceuticals’ drug for MASH; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Virginia high school admissions case could be legal follow
Next article： With competition flaring, obesity drug hits goal in liver disease study

hotspot

WSS

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

Custom gene therapy hints at new path for rare disease treatments

Biden tests positive for Covid

6 phony surgeries that take placebo to the extreme

6 phony surgeries that take placebo to the extreme

Why palliative psychiatry is worth discussing

Wikipedia

Wikipedia

leisure time

Continuity nursing helped my family in our darkest PICU moments

At Orexo, a ‘turning point’ for everything but digital health

At least 13 dead in Texas as scorching temps continue

Doctors find melanoma drugs effective against rare brain cancer

Heart attack and stroke risk calculators need revising

STAT Virtual Event: The State of Biosimilars: What to Watch

Apple is now the first public company to be valued at $3 trillion

Medicare to cover more brain scans for Alzheimer’s patients

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Readout Newsletter: Wegovy, dialysis, Humira, Vir, and more

entertainment

FDA approves RSV monoclonal antibody for infants, toddlers

Alabama frozen embryo ruling has major implications for IVF clinics

A new nitrogen execution bill also undermines medical licensing

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

Medicare has a new plan to address drug shortages

Obesity drugs seen as possible treatment for liver disease MASH

Wikipedia

hotspot

hotspot

explore